亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Circulating tumor DNA-based molecular residual disease detection for the monitoring of high-grade serous ovarian cancer.

医学 浆液性液体 卵巢癌 肿瘤科 内科学 微小残留病 化疗 浆液性卵巢癌 生物标志物 癌症 生物化学 化学 白血病
作者
Xiangxian Ying,Xiaocui Zheng,Yizhi Wang,Jiarui Li,Xing Li,Guomin Lin,Kai Wang,Xipeng Wang
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (16_suppl): e17600-e17600
标识
DOI:10.1200/jco.2023.41.16_suppl.e17600
摘要

e17600 Background: The current standard treatment of epithelial ovarian cancer includes surgery and platinum-based chemotherapy. Most of the patients are sensitive, but still over 70% of patients have recurrence or disease progression. Post-operative circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) test can be a potential biomarker for monitoring the disease. Methods: Stage II-IV high-grade serous ovarian cancer (HGSOC) patients were recruited in this study. Tumor tissues were collected for whole exome sequencing (WES; 300x). Germline mutations were excluded by paired white blood cell test. Proprietary algorithm was used to select 30-40 single nucleotide variants (SNV) for each patient. Blood samples were collected at diagnosis, after surgery, after chemotherapy, and during adjuvant treatment, and MRD was detected by multiplex polymerase chain reaction (PCR)-based sequencing (100,000x) using the customized panel. Results: At the time of analysis, WES was performed in 20 patients, of which 11 of them harbored HRR pathway-related mutations, including 5 BRCA1, 4 BRCA2, 1 ATM, and 1 FANCL. 7 patients had completed MRD monitoring for 3 times (pre-surgery, post-surgery, and post-chemotherapy). 71.4% (5/7) of patients were positive for MRD at baseline, with a median variant allelic frequency (VAF) of 2.79%. The VAF at baseline was positively associated with CA125 level at baseline (Pearson R = 0.937,p = 0.002). 2 patients were positive for MRD after surgery (VAF = 0.09% and 0.04%). One of them presented with multiple diverse lesions and the CA125 level returned normal after surgery and 8 cycles of chemotherapy. Another patient had an abnormal CA125 level of 1597 U/ml after surgery. All the 7 patients were negative for MRD after completion of chemotherapy. Follow-up is ongoing. Conclusions: We preliminary proved the feasibility of dynamic monitoring with MRD in epithelial ovarian cancer patients. Over 70% of HGSOC patients were MRD-positive at baseline. The MRD status was generally consistent with the clinical status of the patients. The performance of MRD in predicting recurrence of HGSOC is still under investigation. Clinical trial information: NCT05027828 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
anugraphics完成签到,获得积分10
刚刚
原神大王的应助被雪山大地采纳,获得10
刚刚
5秒前
5秒前
vfdhjng发布了新的文献求助10
5秒前
完美世界的应助被撩寮采纳,获得10
8秒前
康子浩发布了新的文献求助10
11秒前
多情嫣然完成签到,获得积分10
15秒前
16秒前
ZaZa完成签到,获得积分10
16秒前
19秒前
summerer发布了新的文献求助10
25秒前
Lucas的应助被科研通管家采纳,获得10
26秒前
852的应助被科研通管家采纳,获得10
27秒前
共享精神的应助被科研通管家采纳,获得10
27秒前
殷宵箫发布了新的文献求助10
27秒前
英姑的应助被科研通管家采纳,获得10
27秒前
含蓄的芝麻完成签到,获得积分10
29秒前
ADAB0002完成签到,获得积分10
30秒前
果冻完成签到 ,获得积分10
31秒前
31秒前
vfdhjng完成签到,获得积分20
33秒前
33秒前
可爱的函函的应助被lx采纳,获得10
35秒前
36秒前
华仔的应助被怡宝采纳,获得10
37秒前
summerer发布了新的文献求助20
38秒前
39秒前
嘻嘻哈哈的应助被Gloria采纳,获得10
39秒前
费洛蒙漩涡完成签到,获得积分10
40秒前
孤独孤风完成签到,获得积分10
40秒前
苹果颖完成签到,获得积分10
41秒前
lx完成签到,获得积分10
42秒前
43秒前
43秒前
科研通AI6.4的应助被殷宵箫采纳,获得10
43秒前
44秒前
鱼鱼鱼完成签到,获得积分10
46秒前
lx发布了新的文献求助10
48秒前
48秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165846
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749858
捐赠科研通 7756681
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553354
邀请新用户注册赠送积分活动 2473622